| Anaemia | Blood and lymphatic system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Leukocytosis | Blood and lymphatic system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Splenic haemorrhage | Blood and lymphatic system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Angina pectoris | Cardiac disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Aortic valve incompetence | Cardiac disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Pericardial effusion | Cardiac disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Supraventricular tachycardia | Cardiac disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Tachycardia | Cardiac disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Ascites | Gastrointestinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Colitis | Gastrointestinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Haematemesis | Gastrointestinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0003 affected51 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Complication associated with device | General disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Pyrexia | General disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Cellulitis | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Endocarditis | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Enterococcal infection | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Pneumonia | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Postoperative wound infection | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Septic shock | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Skin infection | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Wound infection | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Wound infection staphylococcal | Infections and infestations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Craniocerebral injury | Injury, poisoning and procedural complications | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Fat embolism | Injury, poisoning and procedural complications | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Femur fracture | Injury, poisoning and procedural complications | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Gastrostomy tube site complication | Injury, poisoning and procedural complications | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Splenic injury | Injury, poisoning and procedural complications | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Toxicity to various agents | Injury, poisoning and procedural complications | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Traumatic liver injury | Injury, poisoning and procedural complications | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Blood culture positive | Investigations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Haematocrit decreased | Investigations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Heart rate increased | Investigations | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Abnormal weight gain | Metabolism and nutrition disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Compartment syndrome | Musculoskeletal and connective tissue disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Fracture nonunion | Musculoskeletal and connective tissue disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Joint contracture | Musculoskeletal and connective tissue disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Acute promyelocytic leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Lung adenocarcinoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Metastasis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Cerebral hypoperfusion | Nervous system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Headache | Nervous system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Hyponatraemic seizure | Nervous system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Hypoxic-ischaemic encephalopathy | Nervous system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Ischaemic stroke | Nervous system disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Mental status changes | Psychiatric disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Anuria | Renal and urinary disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Acute respiratory distress syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0003 affected51 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0002 affected51 at risk
|
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0003 affected51 at risk
|
| Decubitus ulcer | Skin and subcutaneous tissue disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Haemodynamic instability | Vascular disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Hypotension | Vascular disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0003 affected51 at risk
|
| Intermittent claudication | Vascular disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Shock | Vascular disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|
| Shock haemorrhagic | Vascular disorders | MedDRA 20.0 | Non-systematic Assessment | | - EG0001 affected51 at risk
|